Extracellular vesicles from patients with Acute Coronary Syndrome impact on ischemia-reperfusion injury-Reference-Cited by-同舟云学术

Extracellular vesicles from patients with Acute Coronary Syndrome impact on ischemia-reperfusion injury

Published:2021-08 Issue: Volume:170 Page:105715
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

D’Ascenzo Fabrizio,Femminò Saveria,Ravera Francesco^ORCID,Angelini Filippo,Caccioppo Andrea,Franchin Luca^ORCID,Grosso Alberto,Comità Stefano,Cavallari Claudia^ORCID,Penna Claudia,De Ferrari Gaetano Maria,Camussi Giovanni,Pagliaro Pasquale,Brizzi Maria Felice^ORCID

Funder

Compagnia di San Paolo

Publisher

Elsevier BV

Subject

Pharmacology

Reference89 articles.

1. 2018 ESC/EACTS Guidelines on myocardial revascularization;Neumann;EuroIntervention,2020

2. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge;Heusch;Eur. Heart J.,2017

3. Myocardial reperfusion injury;Yellon;N. Engl. J. Med.,2007

4. No-reflow phenomenon and prognosis in patients with acute myocardial infarction;Ito;Nat. Clin. Pract. Cardiovasc. Med.,2006

5. Lethal reperfusion injury in acute myocardial infarction: facts and unresolved issues;Garcia-Dorado;Cardiovasc. Res.,2009

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vagal nerve stimulation in myocardial ischemia/reperfusion injury: from bench to bedside;Bioelectronic Medicine;2024-09-13

2. Research progress of exosomes from different sources in myocardial ischemia;Frontiers in Cardiovascular Medicine;2024-09-12

3. Extrahepatic Bile Duct Organoids as a Model to Study Ischemia/Reperfusion Injury During Liver Transplantation;Transplant International;2024-09-11

4. Circulating extracellular vesicles as biomarkers in the diagnosis, prognosis and therapy of cardiovascular diseases;Frontiers in Cardiovascular Medicine;2024-09-02

5. Novel NLRP3 inhibitor INF195: Low doses provide effective protection against myocardial ischemia/reperfusion injury;Vascular Pharmacology;2024-09